首页> 外文期刊>Vascular pharmacology >The vasohibin family: Novel regulators of angiogenesis.
【24h】

The vasohibin family: Novel regulators of angiogenesis.

机译:血管抑制素家族:血管新生的新型调节剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Angiogenesis is thought to be regulated by the local balance between angiogenesis stimulators and angiogenesis inhibitors. A number of endogenous regulators of angiogenesis have been found in the body. We recently isolated vasohibin-1 (VASH1) as a negative feedback regulator of angiogenesis produced by endothelial cells, and VASH2 as a homologue of VASH1 thereafter. We found that VASH1 was expressed in endothelial cells to terminate angiogenesis, whereas VASH2 promoted angiogenesis, in the mouse model of angiogenesis. This mini-review will focus on the vasohibin family in relation to the regulation of angiogenesis.
机译:血管生成被认为是由血管生成刺激剂和血管生成抑制剂之间的局部平衡调节的。在体内已经发现了许多内源性的血管生成调节剂。我们最近分离出血管抑制素-1(VASH1)作为内皮细胞产生的血管生成的负反馈调节剂,而VASH2作为其后VASH1的同源物。我们发现,VASH1在内皮细胞中表达以终止血管生成,而VASH2在血管生成的小鼠模型中促进了血管生成。这份小型综述将重点探讨血管生成的调控相关的血管抑制素家族。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号